Callen T. Wallace

Callen T. Wallace

Auto-generated profile, based on publicly available information

Callen T. Wallace

Department of Cell Biology, Center for Biologic Imaging, University of Pittsburgh School of Medicine, Pittsburgh, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Autophagy
Verified
Journal Article
Closed access
UGUrvi Gupta
Urvi Gupta
SGSayan Ghosh
Sayan Ghosh
CWCallen T. Wallace
Callen T. Wallace
PSPeng Shang
Peng Shang
YXYing Xin
Ying Xin
DSDebasish Sinha
Debasish Sinha
In dry age-related macular degeneration (AMD), LCN2 (lipocalin 2) is upregulated. Whereas LCN2 has been implicated in AMD pathogenesis, the mechanism remains unknown. Here, we report that in retinal pigmented epithelial (RPE) cells, LCN2 regulates macroautophagy/autophagy, in addition to maintaining iron homeostasis. LCN2 binds to ATG4B to form an LCN2-ATG4B-LC3-II complex, thereby regulating ATG4B activity and LC3-II lipidation. Thus, increased LCN2 reduced autophagy flux. Moreover, RPE cells from cryba1 KO, as well as sting1 KO and Sting1Gt mutant mice (models with abnormal iron chelation), showed decreased autophagy flux and increased LCN2, indicative of CGAS- and STING1-mediated inflammasome activation. Live cell imaging of RPE cells with elevated LCN2 also showed a correlation between inflammasome activation and increased fluorescence intensity of the Liperfluo dye, indicative of oxidative stress-induced ferroptosis. Interestingly, both in human AMD patients and in mouse models with a dry AMD-like phenotype (cryba1 cKO and KO), the LCN2 homodimer variant is increased significantly compared to the monomer. Sub-retinal injection of the LCN2 homodimer secreted by RPE cells into NOD-SCID mice leads to retinal degeneration. In addition, we generated an LCN2 monoclonal antibody that neutralizes both the monomer and homodimer variants and rescued autophagy and ferroptosis activities in cryba1 cKO mice. Furthermore, the antibody rescued retinal function in cryba1 cKO mice as assessed by electroretinography. Here, we identify a molecular pathway whereby increased LCN2 elicits pathophysiology in the RPE, cells known to drive dry AMD pathology, thus providing a possible therapeutic strategy for a disease with no current treatment options. Abbreviations: ACTB: actin, beta; Ad-GFP: adenovirus-green fluorescent protein; Ad-LCN2: adenovirus-lipocalin 2; Ad-LCN2-GFP: adenovirus-LCN2-green fluorescent protein; LCN2AKT2: AKT serine/threonine kinase 2; AMBRA1: autophagy and beclin 1 regulator 1; AMD: age-related macular degeneration; ARPE19: adult retinal pigment epithelial cell line-19; Asp278: aspartate 278; ATG4B: autophagy related 4B cysteine peptidase; ATG4C: autophagy related 4C cysteine peptidase; ATG7: autophagy related 7; ATG9B: autophagy related 9B; BLOC-1: biogenesis of lysosomal organelles complex 1; BLOC1S1: biogenesis of lysosomal organelles complex 1 subunit 1; C57BL/6J: C57 black 6J; CGAS: cyclic GMP-AMP synthase; ChQ: chloroquine; cKO: conditional knockout; Cys74: cysteine 74; Dab2: DAB adaptor protein 2; Def: deferoxamine; DHE: dihydroethidium; DMSO: dimethyl sulfoxide; ERG: electroretinography; FAC: ferric ammonium citrate; Fe2+: ferrous; FTH1: ferritin heavy chain 1; GPX: glutathione peroxidase; GST: glutathione S-transferase; H2O2: hydrogen peroxide; His280: histidine 280; IFNL/IFNλ: interferon lambda; IL1B/IL-1β: interleukin 1 beta; IS: Inner segment; ITGB1/integrin β1: integrin subunit beta 1; KO: knockout; LC3-GST: microtubule associated protein 1 light chain 3-GST; C-terminal fusion; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; LCN2: lipocalin 2; mAb: monoclonal antibody; MDA: malondialdehyde; MMP9: matrix metallopeptidase 9; NLRP3: NLR family pyrin domain containing 3; NOD-SCID: nonobese diabetic-severe combined immunodeficiency; OS: outer segment; PBS: phosphate-buffered saline; PMEL/PMEL17: premelanosome protein; RFP: red fluorescent protein; rLCN2: recombinant LCN2; ROS: reactive oxygen species; RPE SM: retinal pigmented epithelium spent medium; RPE: retinal pigment epithelium; RSL3: RAS-selective lethal; scRNAseq: single-cell ribonucleic acid sequencing; SD-OCT: spectral domain optical coherence tomography; shRNA: small hairpin ribonucleic acid; SM: spent medium; SOD1: superoxide dismutase 1; SQSTM1/p62: sequestosome 1; STAT1: signal transducer and activator of transcription 1; STING1: stimulator of interferon response cGAMP interactor 1; TYR: tyrosinase; VCL: vinculin; WT: wild type.

21 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
OBOfer Beharier
Ofer Beharier
VTVladimir A. Tyurin
Vladimir A. Tyurin
JGJulie P. Goff
Julie P. Goff
JGJennifer Guerrero-Santoro
Jennifer Guerrero-Santoro
KKKazuhiro Kajiwara
Kazuhiro Kajiwara
YSYoel Sadovsky
Yoel Sadovsky
Significance: Placental dysfunction has been causally linked to major pregnancy complications that are implicated in maternal–fetal morbidity and mortality, but the mechanisms underlying placental dysfunction are largely unknown. The recently identified ferroptotic cell death is characterized by excessive accumulation of hydroperoxide phosphatidylethanolamines. While oxidative damage commonly defines placental dysfunction, the role of ferroptosis in this process is largely unknown. We found that preterm birth is associated with ferroptotic signals, and that inhibition of GPX4, which converts unstable lipid hydroperoxides to nontoxic lipid alcohols, causes ferroptotic injury in primary human trophoblasts and in mouse pregnancy. Importantly, we found that the phospholipase PLA2G6 mitigates trophoblast and placental ferroptosis. Together, we identified placental ferroptosis and established a role for PLA2G6 in attenuating ferroptosis.

4 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
WWWeikang Wang
Weikang Wang
DDDiana Douglas
Diana Douglas
JZJingyu Zhang
Jingyu Zhang
SKSangeeta Kumari
Sangeeta Kumari
MEMetewo Selase Enuameh
Metewo Selase Enuameh
JXJianhua Xing
Jianhua Xing
Live-cell imaging in multidimensional feature space reveals parallel transition paths of epithelial-to-mesenchymal transition.

3 June 2017 in OncoImmunology
Verified
Journal Article
Open access
AWAliyah M. Weinstein
Aliyah M. Weinstein
LCLu Chen
Lu Chen
EBEmily A. Brzana
Emily A. Brzana
PPPrashanti R. Patil
Prashanti R. Patil
JTJennifer L. Taylor
Jennifer L. Taylor
Walter J StorkusWalter J Storkus
Walter J Storkus
We have previously reported that direct injection of dendritic cells (DC) engineered to express the Type-1 transactivator Tbet (i.e., DC.Tbet) into murine tumors results in antitumor efficacy in association with the development of structures resembling tertiary lymphoid organs (TLO) in the tumor microenvironment (TME). These TLO contained robust infiltrates of B cells, DC, NK cells, and T cells in proximity to PNAd+ blood vessels; however, they were considered incomplete, since the recruited B cells failed to organize into classic germinal center-like structures. We now report that antitumor efficacy and TLO-inducing capacity of DC.Tbet-based i.t. therapy is operational in peripheral lymph node-deficient LTA−/− mice, and that it is highly dependent upon a direct Tbet target gene product, IL-36γ/IL-1F9. Intratumoral DC.Tbet fails to provide protection to tumor-bearing IL-36R−/− hosts, or to tumor-bearing wild-type recipient mice co-administered rmIL-1F5/IL-36RN, a natural IL-36R antagonist. Remarkably, the injection of tumors with DC engineered to secrete a bioactive form of mIL-36γ (DC.IL36γ) also initiated therapeutic TLO and slowed tumor progression in vivo. Furthermore, DC.IL36γ cells strongly upregulated their expression of Tbet, suggesting that Tbet and IL-36γ cooperate to reinforce each other's expression in DC, rendering them competent to promote TLO formation in an “immunologically normalized,” therapeutic TME.

3 April 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SCStephen D. Carter
Stephen D. Carter
CHCheri M. Hampton
Cheri M. Hampton
RLRobert Langlois
Robert Langlois
RMRoberto Melero
Roberto Melero
ZFZachary J. Farino
Zachary J. Farino
ZFZachary Z. Freyberg
Zachary Z. Freyberg
Ribosome-associated vesicles are a novel, dynamic ER-derived organelle.

12 October 2020 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
SHSong My Hoang
Song My Hoang
NKNicole Kaminski
Nicole Kaminski
RBRagini Bhargava
Ragini Bhargava
JBJonathan Barroso-González
Jonathan Barroso-González
MLMichelle L. Lynskey
Michelle L. Lynskey
RORoderick J. O’sUllivan
Roderick J. O’sUllivan